Inozyme Pharma (NASDAQ:INZY) Price Target Lowered to $15.00 at Needham & Company LLC
Inozyme Pharma (NASDAQ:INZY – Free Report) had its price target trimmed by Needham & Company LLC from $23.00 to $15.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research analysts have also recently commented on INZY. Raymond James began coverage on […]
Inozyme Pharma (NASDAQ:INZY – Free Report) had its price target trimmed by Needham & Company LLC from $23.00 to $15.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research analysts have also recently commented on INZY. Raymond James began coverage on […]
